---
figid: PMC7492550__fmed-07-00517-g0001
figtitle: Identified mechanisms of molecular resistance to anti-TNF therapy in IBD
  patients
organisms:
- Faecalibacterium prausnitzii
- Eubacterium rectale
- Streptococcus mitis
- Clostridium colinum
- Homo sapiens
- gut metagenome
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC7492550
filename: fmed-07-00517-g0001.jpg
figlink: pmc/articles/PMC7492550/figure/F1/
number: F1
caption: Overview of identified mechanisms of molecular resistance to anti-TNF therapy
  in IBD patients. (1) Cellular composition of IgG plasma cells, inflammatory mononuclear
  phagocytes, activated T cells, and stromal cells (GIMATS module). (2) Excessive
  IL-23 production by CD14+ gut macrophages drive expansion of apoptosis-resistant
  IL23R+TNFR2+ T cells. (3) Overexpression of intestinal oncostatin M (OSM). (4) Overexpression
  of T cell derived IL-22BP. (5) Heightened expression of the IL-7R dependent signaling
  pathway that specifically regulates effector T cell homing to the gut by controlling
  alpha4 and beta7 integrin expression.
papertitle: 'Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict
  Response to Anti-TNF?.'
reftext: Raja Atreya, et al. Front Med (Lausanne). 2020;7:517.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8058928
figid_alias: PMC7492550__F1
figtype: Figure
redirect_from: /figures/PMC7492550__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7492550__fmed-07-00517-g0001.html
  '@type': Dataset
  description: Overview of identified mechanisms of molecular resistance to anti-TNF
    therapy in IBD patients. (1) Cellular composition of IgG plasma cells, inflammatory
    mononuclear phagocytes, activated T cells, and stromal cells (GIMATS module).
    (2) Excessive IL-23 production by CD14+ gut macrophages drive expansion of apoptosis-resistant
    IL23R+TNFR2+ T cells. (3) Overexpression of intestinal oncostatin M (OSM). (4)
    Overexpression of T cell derived IL-22BP. (5) Heightened expression of the IL-7R
    dependent signaling pathway that specifically regulates effector T cell homing
    to the gut by controlling alpha4 and beta7 integrin expression.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF1B
  - IL7
  - LINC02605
  - DCLK1
  - ADGRL1
  - CLU
  - AKR1C4
  - GZMB
  - POLR3K
  - TCL1A
  - IL23R
  - OSM
  - CCM2
  - IL7R
  - IL37
  - IL23A
  - IGBP1
  - IL22RA2
  - CD14
  - NDUFA2
  - tnfrsf1b
  - il7
  - il23r
  - osm
  - il7r
---
